Financials

	2024	2025
Net sales	359K 3.76K 3.24K 3.03K 2.77K 5.22K 5.24K 36.01K 14.05K 181K 14.1K 13.8K 601K	1.88M 19.67K 16.95K 15.89K 14.51K 27.33K 27.42K 189K 73.57K 949K 73.85K 72.25K 3.15M
Net income	-1.46M -15.29K -13.17K -12.35K -11.27K -21.24K -21.31K -147K -57.17K -738K -57.39K -56.14K -2.45M	57K 596.4 513.91 481.85 439.85 828.62 831.26 5.72K 2.23K 28.77K 2.24K 2.19K 95.41K
Net Debt	-211K -2.21K -1.9K -1.78K -1.63K -3.07K -3.08K -21.16K -8.26K -107K -8.29K -8.11K -353K	-222K -2.32K -2K -1.88K -1.71K -3.23K -3.24K -22.27K -8.69K -112K -8.72K -8.53K -372K

* Estimated data More financial data

Company Profile

Amerise Biosciences Limited is an India-based company. The Company is not engaged in any activity. The Company did not generate any revenue.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
26-08-31	₹0.8000	-4.76%	40,141
26-08-28	₹0.8400	0.00%	5,512
26-08-27	₹0.8400	+5.00%	75,743
26-08-26	₹0.8000	-3.61%	186,388
26-08-25	₹0.8300	-1.19%	25,922

Delayed Quote Bombay S.E.

More quotes

Market Closed - Bombay S.E. 06:02:24 2026-08-31 EDT			5-day change	1st Jan Change
0.8000 ^INR	-4.76%		-3.61%	+31.15%

08-03	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-05	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	38.98M 408K 351K 330K 301K 567K 568K 3.91M 1.53M 19.68M 1.53M 1.5M 65.25M	P/E 2024	-29.8x	P/E 2025	1,056x
Enterprise Value	38.76M 406K 349K 328K 299K 563K 565K 3.89M 1.52M 19.57M 1.52M 1.49M 64.87M	EV / Sales 2024	121x	EV / Sales 2025	31.9x
Free-Float	64.18%	Yield 2024 *	-	Yield 2025	-

08-03	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-05	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-02	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-02	Amerise Biosciences appoints Albert Hines as CFO	RE
02-02	Amerise Biosciences Limited Announces Chief Financial Officer Changes, Effective February 2, 2026	CI
02-02	Amerise Biosciences Limited Announces Board Changes, Effective February 2, 2026	CI
11-05	Amerise Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-09-24	Amerise Biosciences Limited Appoints Kelash Bunkar as Independent Director, Effective 23 September 2025	CI
25-07-24	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-05-19	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
25-02-03	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
25-02-03	Amerise Biosciences Limited Announces Resignation of Niraj Vaghela as Independent Director	CI
25-01-27	Swagtam Trading & Services Limited announced that it expects to receive INR 61.904375 million in funding from Jalees Commercial Limited, Shree Ganesh Bio-Tech Limited, Amerise Biosciences Limited, Saianand Commercial Limited and other investors	CI

1 day	-4.76%
1 week	-3.61%
Current month	-20.79%
1 month	-20.79%
3 months	+12.68%
6 months	+29.03%
Current year	+31.15%

Amerise Biosciences Limited Stock

Stocks

AMARDEE6

INE673C01020

Investment Holding Companies

Valuation : Amerise Biosciences Limited

Chart: Amerise Biosciences Limited

Latest news : Amerise Biosciences Limited

Quotes and Performance

Price Extremes

Managers and Directors : Amerise Biosciences Limited

Shell Companies

Financials

Company Profile

Quotes

1 week	0.8	0.84
1 month	0.8	1.03
Current year	0.5	1.03
1 year	0.5	1.03
3 years	0.5	1.45
5 years	0.5	2.73
10 years	0.5	2.73

Manager	Title	Age	Since
Albert Hines DFI	Director of Finance/CFO	-	2026-02-01
Soni Pandiya CMP	Compliance Officer	-	2026-04-14

Director	Title	Age	Since
Manisha Maneklal Patel BRD	Director/Board Member	57	2019-06-23
Niraj Vijaybbai Vaghela BRD	Director/Board Member	29	2022-07-22
Albert Hines BRD	Director/Board Member	-	2026-02-01

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMERISE BIOSCIENCES LIMITED	-4.76%	-3.61%	+15.94%	+25.00%	581K
CHURCHILL CAPITAL CORP XI	-4.19%	-5.11%	-	-	778M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	-0.10%	-	-	646M
CHURCHILL CAPITAL CORP XII	+0.37%	+1.21%	-	-	602M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.54%	-0.39%	-	-	600M
CANTOR EQUITY PARTNERS IV, INC.	-0.10%	+0.19%	+2.17%	-	592M
CENTIEL AG	-1.71%	-3.36%	+273.54%	-79.57%	592M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.43%	-0.87%	-	-	569M
CHURCHILL CAPITAL CORP XIII	0.00%	+0.76%	-	-	512M
Average	-1.27%	-1.30%	+97.22%	-27.29%	543.48M
Weighted average by Cap.	-0.96%	-1.72%	+137.77%	-79.47%